EyePoint Pharmaceuticals
EYPT
EYPT
151 hedge funds and large institutions have $401M invested in EyePoint Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.29% less ownership
Funds ownership: 109.06% → 107.77% (-1.3%)
27% less capital invested
Capital invested by funds: $553M → $401M (-$152M)
Holders
151
Holding in Top 10
3
Calls
$1.63M
Puts
$1.38M
Top Buyers
| 1 | +$2.44M | |
| 2 | +$2.39M | |
| 3 | +$2.17M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.05M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$1.99M |
Top Sellers
| 1 | -$6.39M | |
| 2 | -$4.32M | |
| 3 | -$4.29M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$2.59M |
| 5 |
Millennium Management
New York
|
-$2.25M |
